Category Archives: Uncategorized

Fathers, Stop Being Such . . . Men!

June is not only for Father’s Day greetings; it is also Men’s Health Month. And if any gender needs an aide memoire to engender the self-awareness to regard and conduct its health, it would be men! I acknowledge there are…

Share

To BioWorld: Farewell! All My Best. With Love, Trista

As many of you know, after six wonderful years with BioWorld, I’m moving on to take a position as associate director of corporate communications with Ironwood Pharmaceuticals. When BioWorld asked me to write a farewell blog post, I jumped at…

Share

@ASCO12: Invisible Gorillas, IgNobel Prizes and What it All Means for Drug Discovery

As I may have mentioned before, I love the IgNobel Prizes. So imagine my delight when I found myself in a session at ASCO’s 2012 annual meeting earlier this week listening to the speaker, Anthony Tolcher, talking about The Invisible…

Share

2010-12 Biotech IPOs Not Performing THAT Bad. Really.

What a difference two weeks makes. When I was researching last week’s BioWorld Insight cover – about how emerging biotech Verastem Inc., mature biotech Ironwood Pharmaceuticals Inc. and specialty pharma firm Clovis Oncology Inc. shared some surprising similarities in how…

Share

He Said What?!?! Best Biotech Quotes of 2011

As BioWorld Insight readers know, our “Word on the Street” column provides a sample of the most entertaining and thought-provoking quotes our staff stumbles upon each week. Some are gathered during interviews, some gleaned from analyst reports, and some overheard…

Share

The Good, the Bad and . . . the Huh? A 2011 Biotech Recap

The past year brought the biotech sector a mixed bag of news. Some of it was positive – for instance, the FDA picked up its drug approval pace in 2011 and, in some cases, even surprised the most hardened biotech…

Share

The Blame Game: BioPharma CEOs Shouldn’t Be Scapegoats

By Ilene Schneider, BioWorld Perspectives Contributing Writer Biopharma CEOs sometimes pay for the sins of their companies. But is it fair to single out just one person when the failure of the company, or the unethical behavior of the company,…

Share

@ASCO2011: Genomics Era of Cancer has Arrived – Like a Tsunami

CHICAGO ‑ As a scientist by training, I tend to look with unbridled optimism at technological advances. So it was striking to me to see how those that are expected to do something useful with such advances sometimes have a…

Share

Can’t We Just Die Anymore?

Everyone loved my grandmother. That’s why they were rather relieved to hear she had died. My grandmother spritely went about her business against the grain of at least six diseases and with the help of four surgeries, six prescription drugs…

Share

HCV Trials Face Daunting Challenge

Recruiting subjects for ongoing Phase III hepatitis C virus (HCV) trials just got a lot harder. Even if the FDA doesn’t step in and force a change in the standard-of-care control arms after last week’s Antiviral Drugs Advisory Committee meetings,…

Share